Skip to main content
. 2021 Jun 5;147(9):2555–2567. doi: 10.1007/s00432-021-03673-9

Fig. 4.

Fig. 4

Kaplan–Meier diagrams for survival analyses in relation to ERR protein expression. a Overall survival (OS) of patients with serous ovarian cancers with regard to expression to ERRβ. b OS and progression-free survival (PFS) of ovarian cancer patients with different tumoral expression of ERRγ; shown is the OS of serous ovarian cancer patients with low and medium expression of ERRγ compared to those expressing high levels of ERRγ and the PFS of all ovarian cancer patients with low and medium expression of ERRγ compared to those expressing high levels of ERRγ. The hazard ratio (HR) is indicated with the 95% confidence interval in brackets